Tradestie Institutional Equity Comparison Engine
XOMA vs IVA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XOMA Overall Edge
XOMA Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to XOMA Royalty Corporation Common Stock (XOMA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, XOMA trades at 21.5x Forward P/E with -3.9% operating margin (-22.6% YoY revenue) versus IVA at N/M Forward P/E and -5980.9% operating margin (-76.7% YoY). In options structure, XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against IVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
XOMA
XOMA 21.5x vs IVA N/M Fwd P/E
Growth & Margin Winner
XOMA
Op Margin -3.9% vs -5980.9% ยท YoY -22.6% vs -76.7%
Momentum & Technical Winner
XOMA
1Y +44.0% vs -12.7% ยท 52W Pos 78% vs 12%
Options & Structure Winner
XOMA
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
XOMA
NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap
$781.8M
1M Return
-3.81%
1Y Return
+43.98%
Forward P/E
21.5x
Unified AI Score
55.8 / 100
HOLD
Tech 40.0
Fund 52.0
Flow 50.0
Mom 64.0
IVA
NASDAQ
Inventiva S.A. American Depository Shares
Pharmaceutical Preparations
$3.33
-9.38% 1D
Market Cap
$927.7M
1M Return
+13.44%
1Y Return
-12.7%
Forward P/E
N/M
Unified AI Score
38.6 / 100
SELL
Tech 38.0
Fund 36.0
Flow 50.0
Mom 21.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XOMA +43.98%
IVA -12.7%
Spread: +12.03 pp (XOMA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XOMA TTM Op. Margin: -3.9%
IVA TTM Op. Margin: -5980.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XOMA vs IVA. Trailing 12-month operating profitability (XOMA -3.9% vs IVA -5980.9%) and valuation multiples (XOMA 21.5x vs IVA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XOMA | IVA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $781.8M | $927.7M | Larger Scale | IVA |
| Trailing P/E Ratio Valuation | 28.2x | N/M | Lower Multiple | XOMA |
| Forward P/E Ratio Valuation | 21.5x | N/M | Lower Multiple | XOMA |
| Revenue Growth (YoY) Growth | -22.6% | -76.7% | Higher Growth | XOMA |
| Operating Margin (TTM) Profitability | -3.9% | -5980.9% | Higher Margin | XOMA |
| Net Profit Margin Profitability | 69.6% | 0.0% | Higher Margin | XOMA |
| Return on Equity (ROE) Capital Efficiency | 34.2% | -989.0% | Higher ROE | XOMA |
| 52-Week Range Position Momentum | 78% ($22โ$45) | 12% ($3โ$7) | Stronger Trend | XOMA |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 37% Vol | 1.14ฮฒ ยท 73% Vol | Lower Realized Risk | XOMA |
| Unified Institutional Score Composite Signal | 55.8 / 100 (HOLD) | 38.6 / 100 (SELL) | Higher Composite | XOMA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XOMA vs IVA Buy Guide
XOMA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
IVA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XOMA nor IVA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.